Juva Life Inc.
JUVAF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $3 | $1 | $2 | $2 |
| % Growth | 114.8% | -14.4% | 9.3% | – |
| Cost of Goods Sold | $2 | $2 | $1 | $3 |
| Gross Profit | $1 | -$1 | $0 | -$1 |
| % Margin | 35.5% | -34.5% | 21.4% | -64.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $2 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $0 | $1 | $1 |
| Operating Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | -15.1% | -67.2% | -42.3% | -105.3% |
| Other Income/Exp. Net | -$0 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$1 | -$2 | -$1 | -$3 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$1 | -$2 | -$1 | -$3 |
| % Margin | -24.6% | -130.8% | -85% | -164.1% |
| EPS | -0.005 | -0.012 | -0.009 | -0.016 |
| % Growth | 59.3% | -32.6% | 43.7% | – |
| EPS Diluted | -0.005 | -0.012 | -0.009 | -0.016 |
| Weighted Avg Shares Out | 164 | 164 | 164 | 164 |
| Weighted Avg Shares Out Dil | 164 | 164 | 164 | 164 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | -$1 | -$0 | -$2 |
| % Margin | 17.4% | -45.4% | -22.2% | -102.8% |